The cells were then washed and placed at 37 C in medium containing 200 M CuSO 4 for 15 min to stimulate endocytosis of PrP and the bound antibody
Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback
Animals should be gently removed from the cage and their tails quickly secured without causing undue stress
Another study emphasized the potential adverse effects of copper exposure on myocardial contractility at recommended daily doses, tolerable maximum intake doses, and twice the tolerable maximum intake level, but the validity of these doses requires verification through extensive experimentation (122)
